Biosimilars for the Treatment of Cancer: A Systematic Review of Published Evidence

Overview of attention for article published in BioDrugs, January 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#29 of 660)
High Attention Score compared to outputs of the same age (91st percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

news: 2 news outlets

twitter: 3 X users

Citations

dimensions_citation: 31 Dimensions

Readers on

mendeley: 97 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 2 news stories from 2 outlets.

Trastuzumab Biosimilar Equivalent in Early HER2+ Breast CA Tx

MedPage Today, 07 Feb 2018

Action Points Efficacy, safety, and immunogenicity were comparable between SB3, a Korean-manufactured biosimilar to trastuzumab …

Trastuzumab Biosimilar Could Lead to Lower Health-Care Costs and Greater Drug Access for Patients With Metastatic Breast Cancer

The ASCO Post, 25 Apr 2017

The importance of these findings cannot be underscored sufficiently. The development of a biosimilar for treatment in this…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.